Several transmembrane transporter proteins may hinder drugs from reaching the target by reducing the concentration of drugs in tumour cells or changing the distribution of drugs in cells, such as drug efflux P‐glycoprotein (P‐gp), multidrug resistance protein (MRP). Here, PGP is linked to neoplasm.